Reliant Pharmaceuticals, Inc. Watch

from S-1/A 159 pages Third-Lien Loan and Guaranty Agreement Dated as of April 13, 2005 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, and Goldman Sachs Credit Partners L.P., as Administrative Agent and Collateral Agent $49,625,000 Senior Secured Credit Facility

from S-1/A 14 pages Third Amendment to Credit Agreement

from S-1/A 7 pages Second Amendment to Credit Agreement

from S-1/A 84 pages Credit Agreement Dated as of August 19, 2004 Among Reliant Pharmaceuticals, Inc., a Delaware Corporation, as Borrower, Merrill Lynch Capital, a Division of Merrill Lynch Business Financial Services Inc., as Agent and as a Lender and the Additional Lenders From Time to Time Party Hereto

from S-1/A 161 pages Credit and Guaranty Agreement Dated as of March 9, 2007 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, Goldman Sachs Credit Partners L.P., as Sole Lead Arranger, Sole Bookrunner, and Syndication Agent and Goldman Sachs Credit Partners L.P., as Administrative Agent and Collateral Agent $215,000,000 Senior Secured Credit Facility

from S-1 14 pages Third Amendment to Credit Agreement

from S-1 7 pages Second Amendment to Credit Agreement

from S-1 6 pages First Amendment to Credit Agreement

from S-1 77 pages Credit Agreement Dated as of August 19, 2004 Among Reliant Pharmaceuticals, Inc., a Delaware Corporation, as Borrower, Merrill Lynch Capital, a Division of Merrill Lynch Business Financial Services Inc., as Agent and as a Lender and the Additional Lenders From Time to Time Party Hereto

from S-1 139 pages Credit and Guaranty Agreement Dated as of March 9, 2007 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, Goldman Sachs Credit Partners L.P., as Sole Lead Arranger, Sole Bookrunner, and Syndication Agent and Goldman Sachs Credit Partners L.P., as Administrative Agent and Collateral Agent $215,000,000 Senior Secured Credit Facility

from S-1/A 1 page 1. Reimbursement of Expenses: Reliant Shall Reimburse Ethypharm for the Expenses Incurred for Transferring Manufacturing Technology to the Facility of Elite Pharmaceuticals, North Vale, New Jersey, in Order to Manufacture Two Technical and One Clinical Cgmp Batch of Ethypharm’s Fenofibrate Formulation During the Year 2002. Such Expenses, Totaling $462,050.55, Shall Be Invoiced to Reliant by a Single Separate and Itemized Invoice by December 18, 2002 and Be Payable to Ethypharm by December 19, 2002. 2. Credit to Reliant: By December 18, 2002, Ethypharm Will Provide Reliant With a Credit Note of $280,000 Against Ethypharm’s Invoice # 2002 09 0051, Dated September 27, 2002. 3. Amendment to Paragraph 4.2[b]: The First Sentence of Paragraph 4.2[b] Is Hereby Amended by Deleting $[***] in the First Sentence and Substituting $[***] in Lieu Thereof. Paragraph 4.2[b][i] Is Hereby Amended by Deleting $[***] in the First Sentence and Substituting $[***] in Lieu Thereof. 4. Miscellaneous: Except as Expressly Provided Herein, All Terms Contained in the License Agreement Shall Remain in Full Force in Effect. Gerard Leduc Chief Operation Officer Ethypharm S.A. Accepted by Reliant Pharmaceuticals, LLC: Name: Title: [***]: Certain Information on This Page Has Been Omitted and Filed Separately With the Commission. Confidential Treatment Has Been Requested With Respect to the Omitted Portions

from S-1/A 20 pages Consent, Waiver and Amendment to Third-Lien Loan and Guaranty Agreement

from S-1 1 page 1. Reimbursement of Expenses: Reliant Shall [***] Ethypharm for the Expenses Incurred for [***], in Order to [***]. Such Expenses, Totaling [***], Shall Be Invoiced to Reliant by a Single Separate and Itemized Invoice by [***] and Be Payable to Ethypharm by [***]. 2. Credit to Reliant: By [***], Ethypharm Will Provide Reliant With a [***], Dated [***]. 3. Amendment to Paragraph 4.2[b]: The First Sentence of Paragraph 4.2[b] Is Hereby Amended by Deleting [***] in the First Sentence and Substituting [***] in Lieu Thereof. Paragraph 4.2[b][i] Is Hereby Amended by Deleting [***] in the First Sentence and Substituting [***] in Lieu Thereof. 4. Miscellaneous: Except as Expressly Provided Herein, All Terms Contained in the License Agreement Shall Remain in Full Force in Effect. Gerard Leouc Chief Operation Officer Ethypharm S.A. Accepted by Reliant Pharmaceuticals, LLC: Name: Title: [***]: Certain Information on This Page Has Been Omitted and Filed Separately With the Commission. Confidential Treatment Has Been Requested With Respect to the Omitted Portions

from S-1 7 pages Second Amendment to Credit Agreement

from S-1 6 pages First Amendment to Credit Agreement

from S-1 78 pages Credit Agreement Dated as of August 19, 2004 Among Reliant Pharmaceuticals, Inc., a Delaware Corporation, as Borrower, Merrill Lynch Capital, a Division of Merrill Lynch Business Financial Services Inc., as Agent and as a Lender and the Additional Lenders From Time to Time Party Hereto

from S-1 112 pages Third-Lien Loan and Guaranty Agreement Dated as of April 13, 2005 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, and Goldman Sachs Credit Partners L.P., as Administrative Agent and Collateral Agent $49,625,000 Senior Secured Credit Facility

from S-1 93 pages Second-Lien Loan and Guaranty Agreement Dated as of April 13, 2005 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, Goldman Sachs Credit Partners L.P., Lender, Lead Arranger, Sole Bookrunner, and Syndication Agent and Silver Point Finance, LLC Administrative Agent and Collateral Agent $30,000,000 Senior Secured Credit Facility

from S-1 101 pages First-Lien Loan and Guaranty Agreement Dated as of April 13, 2005 Among Reliant Pharmaceuticals, Inc., Certain Subsidiaries of Reliant Pharmaceuticals, Inc., as Guarantor Subsidiaries, Various Lenders, Goldman Sachs Credit Partners L.P., Lender, Lead Arranger, Sole Bookrunner, and Syndication Agent and the Bank of New York Administrative Agent and Collateral Agent $120,000,000 Senior Secured Credit Facility